Dovganyuk I. Clinical, Morphological and Biochemical Grounds for "Ceruloplasmin" Use in complex Treatment of Chronic Atrophic Gastritis and Peptical Stomach Ulcer

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0407U003520

Thesis Registration Form

0407U003520.pdf

Applicant for

Specialization

  • 14.01.36 - Гастроентерологія

04-09-2007

Specialized Academic Board

Д 08.601.02

State institution "Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine"

Essay

The correlation of morphologic deragements of stomach mucous membrane with activation of free radical processes were evaluated as well as their influence on chronic atrophic gastritis progress and stomach peptic ulcer. Characteristic morphological changes of mucous membrane of above mentioned diseases were revealed and systemized. The deragements of oxidant - antioxidant balance system were identified by the contents level of ceruloplasminum in stomach mucous membrane bioptats, ceruloplasminum concentration, activity of malonic dialdehyde and ornityndecorbacsilasis in blood serum and the contents of echinociti in peripheral blood.

Read more

Files

Автореферат ИА.doc

Автореферат.doc

Дисерт перепл з карт.doc

Дисерт перепл з карт.doc

Similar theses

0521U101202

Elina G. Manzhalii

Hepatic Encephalopathy: Aspects of Diagnostics, Clinical and Laboratory and Psychological Peculiarities, and Treatment Optimization

0521U100881

Katerina V. Pivtorak

Diagnosis, prognosis and pharmacological correction of endothelial dysfunction in non-alcoholic fatty liver disease (clinical and experimental study)

0420U102383

Psaryeva Inessa V.

Clinical, diagnostic and prognostic value of inflammation biomarkers in patients with ulcerative colitis

0420U102382

Stan Mychailo Petrovych Mychailo P

Peculiar features of the course of gastroesophageal reflux disease and its management in patients with carbon and lipid metabolism disorders

0420U102152

Konenko Irina S

Predictors of fibrosis progression in patients with chronic diffuse liver diseases